PSY72 – Orphan Drug Pricing In France: Influence of Main Factors

H. Grand, Anne-Laure Samson and M. Aulois-Griot

Post-Print from HAL

Abstract: Orphan drugs (OD) require considerable expenditures, which causes difficulties in their market access. For several years, the price of these new therapies has often been criticized and considered as too high. However few studies about OD pricing mechanisms are available. The aim of the paper is to highlight the main factors that influence OD pricing in France.

Keywords: Drugs; Health expenditures (search for similar items in EconPapers)
Date: 2014-11
References: Add references at CitEc
Citations:

Published in Value in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014, 17 (7), ⟨10.1016/j.jval.2014.08.1702⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01685910

DOI: 10.1016/j.jval.2014.08.1702

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().